UNSPSC 51281509: Terizidone

This classification denotes an antitubercular agent with the molecular formula C14H14N4O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1199LEX5N8, chemically known as 4,4-(p-phenylenebis(methyleneamino))di-(isoxazolidin-3-one) but generally known as terizidone, which bears US NIH Compound Identifier 65720. European Medicines Agency schedules Terizidone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB15487MIG. The term TERIZIDONE is an International Non-Proprietary Name.

UNSPSC 51281509 Terizidone (Commodity) encompasses pharmaceutical products and related medical supplies that state and local governments procure for public health, emergency response, and pharmacy benefit programs. Recent solicitations show state and local buyers acquiring naloxone and drug deactivation systems, generic pharmaceuticals and over-the-counter products through cooperative purchasing agreements, and medical and first aid supplies for emergency medical services. The issuing bodies include county health departments, state health and human services commissions, city fire departments, and multi-state cooperative purchasing alliances that aggregate demand across participating jurisdictions. Work under this code ranges from annual naloxone and harm-reduction supply procurement to large-scale generic pharmaceutical contracting with authorized pharmaceutical wholesalers, reflecting the diversity of end-use applications across public health and emergency response functions.

Recent activity spans Florida, Texas, and Minnesota. Seminole County, Florida issued IFB 60459723LAS (posted June 30, 2026, due July 26, 2023) seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building. The Texas Health and Human Services Commission issued RFI HHS0017013 (posted April 3, 2026, due April 3, 2026) to solicit vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program. The City of Tampa issued IFB 26P00145 (posted March 25, 2026, due March 13, 2026) for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division, designated as a sheltered market opportunity for certified Small Local Business Enterprises with an estimated contract value of $700,000. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued RFP S1070000015802 (posted January 20, 2026, due March 26, 2026) to establish multiple contracts for generic multi-source pharmaceuticals and over-the-counter products distributed across participating state and local facilities, with awarded vendors required to work through three authorized wholesalers and products effective July 1, 2026.